MDCXW Market Analysis

News & Sentiment

50 articles · sorted by date
Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Fundamentals

Updated daily after market close
P/E ratio
EPS (TTM)0.0% YoY
Profit margin0.0%
Market cap

Valuation

Forward P/E
PEG ratio
P/B
P/S (TTM)
EV/EBITDA

Profitability & growth

ROE (TTM)
-2865.0%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
-0.65

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

About Medicus Pharma Ltd. Warrant

Company profile

Medicus Pharma Ltd. (MDCXW) is a forward-looking pharmaceutical company focused on the development and commercialization of groundbreaking therapies to meet pressing healthcare needs. With a well-defined pipeline bolstered by innovative research and strict adherence to regulatory standards, the company is adept at navigating the evolving medical landscape. Medicus Pharma is dedicated to improving patient outcomes while simultaneously creating sustainable value for its investors, positioning itself as a key player in the pharmaceutical sector.

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
300 CONSHOHOCKEN STATE ROAD, WEST CONSHOHOCKEN, PA
Fiscal year end
December
Latest quarter
Mar 31, 2026
Shares outstanding$0
52W high$2.50
52W low$0.31

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer